Furthermore, GM-CSF (granulocyte-macrophage colony-stimulating factor), a cytokine secreted by fibroblasts, immune and endothelial cells, was able to shift macrophage production of VEGF towards sVEGFR1 in hypoxic conditions, which resulted in reduction of tumor mass (Table 1). The gene discussed is CSF2; the disease is neoplasm.